作者
Preetam Nath, Raj Kumar, Bipadabhanjan Mallick, Swati Das, Anil Anand, Sarat C Panigrahi, Ajay Duseja, Subrat K Acharya, Yogesh K Chawla, Dibya L Praharaj
发表日期
2022/7
来源
Cureus
卷号
14
期号
7
出版商
Cureus Inc.
简介
Background
The presence of metabolic syndrome (MS) is associated with increased disease severity in patients with coronavirus disease 2019 (COVID-19). Non-alcoholic fatty liver disease (NAFLD) associated with or without MS may be related to increased morbidity and mortality in COVID-19, but large Indian studies are lacking. The present study was carried out to assess the impact of NAFLD on the clinical outcomes in patients with COVID-19 infection.
Methods
All patients with COVID-19 hospitalized at a tertiary care hospital in eastern India from April 4 to December 31, 2020, were included in the study. Patients who underwent non-contrast CT (NCCT) chest were evaluated for the presence of hepatic steatosis based on a validated criterion liver attenuation (HU) value lower than the spleen, absolute liver attenuation lower than 40 HU, and liver to spleen attenuation ratio less than 1. Patients were divided into two …
学术搜索中的文章
P Nath, R Kumar, B Mallick, S Das, A Anand… - Cureus, 2022